2012 Q1 Form 10-Q Financial Statement
#000114420412027198 Filed on May 09, 2012
Income Statement
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
Revenue | $3.861M | $690.0K | $4.128M |
YoY Change | -6.47% | -91.0% | 385.65% |
Cost Of Revenue | $1.320M | $400.0K | $778.0K |
YoY Change | 69.67% | -90.87% | |
Gross Profit | $2.408M | $290.0K | $5.222M |
YoY Change | -53.89% | -91.16% | |
Gross Profit Margin | 62.37% | 42.03% | 126.5% |
Selling, General & Admin | $1.630M | $8.390M | $1.990M |
YoY Change | -18.09% | 7.15% | 22.84% |
% of Gross Profit | 67.69% | 2893.1% | 38.11% |
Research & Development | $8.847M | $760.0K | $10.56M |
YoY Change | -16.25% | -88.81% | 17.63% |
% of Gross Profit | 367.4% | 262.07% | 202.28% |
Depreciation & Amortization | $930.0K | $930.0K | $880.0K |
YoY Change | 5.68% | 4.49% | 25.71% |
% of Gross Profit | 38.62% | 320.69% | 16.85% |
Operating Expenses | $8.847M | $9.150M | $10.56M |
YoY Change | -16.25% | -24.57% | 17.76% |
Operating Profit | -$6.065M | -$8.860M | -$5.038M |
YoY Change | 20.39% | 0.11% | |
Interest Expense | $160.0K | -$60.00K | -$10.00K |
YoY Change | -1700.0% | -118.75% | -105.88% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$5.900M | -$8.910M | -$5.050M |
YoY Change | 16.83% | 4.45% | -36.56% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$5.904M | -$8.910M | -$5.052M |
YoY Change | 16.86% | 4.45% | -36.53% |
Net Earnings / Revenue | -152.91% | -1291.3% | -122.38% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$0.67 | -$1.04 | -$0.62 |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $45.60M | $27.00M | $50.20M |
YoY Change | -9.16% | -24.79% | -27.67% |
Cash & Equivalents | $45.61M | $27.00M | $50.23M |
Short-Term Investments | |||
Other Short-Term Assets | $3.800M | ||
YoY Change | |||
Inventory | $263.0K | $279.0K | $1.100M |
Prepaid Expenses | $235.0K | ||
Receivables | $815.0K | $1.374M | $6.400M |
Other Receivables | $3.154M | $3.837M | $4.500M |
Total Short-Term Assets | $49.84M | $32.49M | $62.30M |
YoY Change | -20.0% | -29.83% | -14.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $17.51M | $18.27M | $17.70M |
YoY Change | -1.09% | 4.41% | 20.41% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.100M | $1.000M | $1.000M |
YoY Change | 10.0% | 11.11% | 25.0% |
Total Long-Term Assets | $18.63M | $19.31M | $18.60M |
YoY Change | 0.15% | 4.97% | 20.78% |
TOTAL ASSETS | |||
Total Short-Term Assets | $49.84M | $32.49M | $62.30M |
Total Long-Term Assets | $18.63M | $19.31M | $18.60M |
Total Assets | $68.46M | $51.81M | $80.90M |
YoY Change | -15.37% | -19.93% | -8.48% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $4.600M | $5.000M | $7.500M |
YoY Change | -38.67% | -20.63% | 38.89% |
Accrued Expenses | $2.327M | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $17.72M | $18.69M | $20.10M |
YoY Change | -11.82% | -1.1% | 1.52% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $6.566M | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $5.623M | $6.566M | $56.10M |
YoY Change | -89.98% | -88.5% | -7.12% |
Total Long-Term Liabilities | $57.20M | $59.19M | $56.10M |
YoY Change | 1.96% | 3.66% | -7.12% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $17.72M | $18.69M | $20.10M |
Total Long-Term Liabilities | $57.20M | $59.19M | $56.10M |
Total Liabilities | $74.92M | $77.88M | $76.20M |
YoY Change | -1.68% | 2.34% | -4.99% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$172.0M | ||
YoY Change | |||
Common Stock | $145.9M | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$6.457M | -$26.08M | $4.705M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $68.46M | $51.81M | $80.90M |
YoY Change | -15.37% | -19.93% | -8.48% |
Cashflow Statement
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.904M | -$8.910M | -$5.052M |
YoY Change | 16.86% | 4.45% | -36.53% |
Depreciation, Depletion And Amortization | $930.0K | $930.0K | $880.0K |
YoY Change | 5.68% | 4.49% | 25.71% |
Cash From Operating Activities | -$6.281M | -$6.610M | -$3.988M |
YoY Change | 57.5% | -17.68% | -55.44% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $810.0K | $710.0K | $2.604M |
YoY Change | -68.89% | -31.73% | -12.03% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $42.00K | -$40.00K | $46.00K |
YoY Change | -8.7% | 0.0% | -215.0% |
Cash From Investing Activities | -$852.0K | -$750.0K | -$2.650M |
YoY Change | -67.85% | -29.91% | -11.67% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $25.40M | $20.60M | |
YoY Change | 23.3% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $25.57M | 20.00K | 20.94M |
YoY Change | 22.15% | -94.12% | |
NET CHANGE | |||
Cash From Operating Activities | -$6.281M | -6.610M | -3.988M |
Cash From Investing Activities | -$852.0K | -750.0K | -2.650M |
Cash From Financing Activities | $25.57M | 20.00K | 20.94M |
Net Change In Cash | $18.44M | -7.340M | 14.30M |
YoY Change | 28.98% | -16.21% | -219.65% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$6.281M | -$6.610M | -$3.988M |
Capital Expenditures | $810.0K | $710.0K | $2.604M |
Free Cash Flow | -$7.091M | -$7.320M | -$6.592M |
YoY Change | 7.57% | -19.29% | -44.65% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2012Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
91891578 | shares |
CY2011Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
50227000 | |
CY2011Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2011Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4705000 | |
CY2011Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2012Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17724000 | |
CY2012Q1 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
8298000 | |
CY2012Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
4858000 | |
CY2012Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
815000 | |
CY2012Q1 | us-gaap |
Assets
Assets
|
68464000 | |
CY2012Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
3154000 | |
CY2012Q1 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1120000 | |
CY2012Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
49781000 | |
CY2012Q1 | us-gaap |
Inventory Net
InventoryNet
|
263000 | |
CY2011Q1 | us-gaap |
Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
|
7000 | |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3988000 | |
CY2012Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2012Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
57197000 | |
CY2012Q1 | us-gaap |
Assets Current
AssetsCurrent
|
49837000 | |
CY2012Q1 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
1793000 | |
CY2012Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
5623000 | |
CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
45605000 | |
CY2012Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
4568000 | |
CY2012Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
68464000 | |
CY2012Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6457000 | |
CY2012Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
17507000 | |
CY2012Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2012Q1 | us-gaap |
Liabilities
Liabilities
|
74921000 | |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
35900000 | |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11323000 | |
CY2011Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18693000 | |
CY2011Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
7540000 | |
CY2011Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
6121000 | |
CY2011Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1374000 | |
CY2011Q4 | us-gaap |
Assets
Assets
|
51805000 | |
CY2011Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
3837000 | |
CY2011Q4 | us-gaap |
Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
|
1043000 | |
CY2011Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
50923000 | |
CY2011Q4 | us-gaap |
Inventory Net
InventoryNet
|
279000 | |
CY2011Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2011Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
59189000 | |
CY2011Q4 | us-gaap |
Assets Current
AssetsCurrent
|
32491000 | |
CY2011Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
1700000 | |
CY2011Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
6566000 | |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
27001000 | |
CY2011Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
5032000 | |
CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
51805000 | |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-26077000 | |
CY2011Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
18271000 | |
CY2011Q4 | us-gaap |
Liabilities
Liabilities
|
77882000 | |
CY2011Q1 | us-gaap |
Gross Profit
GrossProfit
|
5222000 | |
CY2011Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
242000 | |
CY2011Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
256000 | |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2650000 | |
CY2011Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1654000 | |
CY2011Q1 | us-gaap |
Revenues
Revenues
|
4128000 | |
CY2011Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
1410000 | |
CY2011Q1 | us-gaap |
Reimbursement Revenue
ReimbursementRevenue
|
2292000 | |
CY2011Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
242000 | |
CY2011Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2561000 | |
CY2011Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
46000 | |
CY2011Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
248000 | |
CY2011Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5052000 | |
CY2011Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10563000 | |
CY2011Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-64000 | |
CY2011Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
778000 | |
CY2011Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
20590000 | |
CY2011Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2604000 | |
CY2011Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5038000 | |
CY2011Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-14000 | |
CY2011Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
14327000 | |
CY2011Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
29000 | |
CY2011Q1 | us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
33000 | |
CY2011Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-88000 | |
CY2011Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1141000 | |
CY2011Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1989000 | |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
20936000 | |
CY2011Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.06 | |
CY2011Q1 | plx |
Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
|
878000 | |
CY2011Q1 | plx |
Supplemental Offering And Stock Issuance Costs
SupplementalOfferingAndStockIssuanceCosts
|
90000 | |
CY2011Q1 | plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
1194000 | |
CY2011Q1 | plx |
Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
|
8271000 | |
CY2011Q1 | plx |
Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
|
81744547 | shares |
CY2011Q1 | plx |
Other Gains Losses
OtherGainsLosses
|
1872000 | |
CY2011Q1 | plx |
Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
|
20680000 | |
CY2011Q1 | plx |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
1000 | |
CY2012Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2012Q1 | dei |
Trading Symbol
TradingSymbol
|
PLX | |
CY2012Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
PROTALIX BIOTHERAPEUTICS, INC. | |
CY2012Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2012Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2012Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2012 | |
CY2012Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2012Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-03-31 | |
CY2012Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001006281 | |
CY2012Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2012Q1 | us-gaap |
Gross Profit
GrossProfit
|
2408000 | |
CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
129000 | |
CY2012Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
36000 | |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-852000 | |
CY2012Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1270000 | |
CY2012Q1 | us-gaap |
Revenues
Revenues
|
3861000 | |
CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
1780000 | |
CY2012Q1 | us-gaap |
Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
|
5000 | |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6281000 | |
CY2012Q1 | us-gaap |
Reimbursement Revenue
ReimbursementRevenue
|
2003000 | |
CY2012Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
129000 | |
CY2012Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-242000 | |
CY2012Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
42000 | |
CY2012Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5904000 | |
CY2012Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8847000 | |
CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
114000 | |
CY2012Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1320000 | |
CY2012Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25388000 | |
CY2012Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
810000 | |
CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6065000 | |
CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
161000 | |
CY2012Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
18604000 | |
CY2012Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
163000 | |
CY2012Q1 | us-gaap |
Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
|
44000 | |
CY2012Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-16000 | |
CY2012Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-2405000 | |
CY2012Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1629000 | |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
25574000 | |
CY2012Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.07 | |
CY2012Q1 | plx |
Depreciation Amortization And Asset Impairment
DepreciationAmortizationAndAssetImpairment
|
930000 | |
CY2012Q1 | plx |
Supplemental Offering And Stock Issuance Costs
SupplementalOfferingAndStockIssuanceCosts
|
150000 | |
CY2012Q1 | plx |
Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
|
829000 | |
CY2012Q1 | plx |
Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
|
6844000 | |
CY2012Q1 | plx |
Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
|
87821078 | shares |
CY2012Q1 | plx |
Other Gains Losses
OtherGainsLosses
|
-133000 | |
CY2012Q1 | plx |
Proceeds From Issuance Of Common Stock Net Of Expenses
ProceedsFromIssuanceOfCommonStockNetOfExpenses
|
25538000 | |
CY2012Q1 | plx |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
2000 |